-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FarFHtvcDPjflnJw4al0OxoK7ojvsQ8Ksa64sTwUfoXFBuSIpnGvuOjgUq+1fVBa Eh/ksgLS6JtRSPlDcNmraw== 0001030653-09-000020.txt : 20091005 0001030653-09-000020.hdr.sgml : 20091005 20091005162024 ACCESSION NUMBER: 0001030653-09-000020 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091001 FILED AS OF DATE: 20091005 DATE AS OF CHANGE: 20091005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CURAGEN CORP CENTRAL INDEX KEY: 0001030653 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061331400 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 322 EAST MAIN STREET CITY: BRANFORD STATE: CT ZIP: 06405 BUSINESS PHONE: 203 481 1104 MAIL ADDRESS: STREET 1: 322 EAST MAIN STREET CITY: BRANFORD STATE: CT ZIP: 06405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZENNER PATRICK J CENTRAL INDEX KEY: 0001139036 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23223 FILM NUMBER: 091105825 MAIL ADDRESS: STREET 1: C/O DENDRITE INTERNATIONAL INC. STREET 2: 1405/1425 ROUTE 206 SOUTH CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2009-10-01 1 0001030653 CURAGEN CORP CRGN 0001139036 ZENNER PATRICK J 322 EAST MAIN STREET BRANFORD CT 06405 1 0 0 0 Common Stock 2009-10-01 4 D 0 10000 D 0 D Employee Stock Option (Right to Buy) 2.73 2009-10-01 4 D 0 15000 D 2010-10-01 Common Stock 15000 0 D Employee Stock Option (Right to Buy) .69 2009-10-01 4 D 0 17500 D 2010-10-01 Common Stock 17500 0 D Employee Stock Option (Right to Buy) 1.09 2009-10-01 4 D 0 17500 D 2010-10-01 Common Stock 17500 0 D Employee Stock Option (Right to Buy) .57 2009-10-01 4 D 0 35000 D 2010-10-01 Common Stock 35000 0 D Disposed of pursuant to merger agreement between issuer and Celldex Therapeutics, Inc. in exchange for 2,739 shares of Celldex Therapeutics, Inc. common stock having a market value of $19.82 per share on the effective date of the merger, October 1, 2009. This option, which vested 100% on May 2, 2007, was assumed by Celldex Therapeutics, Inc. in the merger and replaced with an option to purchase 4,108 shares of Celldex Therapeutics, Inc. common stock for $9.97 per share. This option, which vested 100% on January 24, 2008, was assumed by Celldex Therapeutics, Inc. in the merger and replaced with an option to purchase 4,793 shares of Celldex Therapeutics, Inc. common stock for $2.52 per share. This option, which vested 100% on May 21, 2008, was assumed by Celldex Therapeutics, Inc. in the merger and replaced with an option to purchase 4,793 shares of Celldex Therapeutics, Inc. common stock for $3.98 per share. This option, which vested 100% on February 11, 2009, was assumed by Celldex Therapeutics, Inc. in the merger and replaced with an option to purchase 9,586 shares of Celldex Therapeutics, Inc. common stock for $2.08 per share. Patrick J. Zenner 2009-10-05 -----END PRIVACY-ENHANCED MESSAGE-----